Medigen Vaccine Biologics : Announcement of the company's cash capital increase subscription date and other related matters (supplemental issue price and banks information)

About this update from Medigen Vaccine Biologics Corp.

Close Today's Information Provided by: Medigen Vaccine Biologics Corporation SEQ_NO 1 Date of announcement 2022/04/21 Time of announcement 18:17:10 Subject Announcement of the company's cash capital increase subscription date and other related matters (supplemental issue price and banks information) Date of events 2022/04/13 To which item it meets paragraph 11 Statement 1.Date of the board of directors resolution or decision by the Company for record date:2022/04/13 2.Whether to adopt shelf registration (Yes, please state issuance period /No): No 3.Effective registration date approved by competent authority:2022/04/12 4.Date of the board of directors resolution for (additional) issuance of shares:2022/03/01 5.Total monetary value of the issuance and number of shares issued: The total amount NT$70,000,000 / 7,000,000 shares outstanding 6.If adopting shelf registration, monetary value and number of shares to be issued this time:NA 7.The remaining monetary value and shares after this issuance when adopting shelf registration:NA 8.Par Value per share:NT$10 9.Issue price:The issue price per share is NT$220(supplemental issue price) 10.Number of shares subscribed for by employees: In accordance with Article 267 of the Companies Act, 10% (700,000 shares) of the total number of new shares to be issued are reserved for subscription by employees of the Company. 11.Ratio of shares subscribed for by existing shareholders: 80% (5,600,000 shares) is subscribed by the original shareholders in proportion to the shareholders' shareholding as recorded in the register of shareholders on the basis date of the capital increase. 12.Method for public sale and no.of shares: Pursuant to Article 28-1 of the Securities and Exchange Act,10% (700,000 shares) of the total amount of new shares issued are allocated for public underwriting. 13.Handling method for fractional shares and shares unsubscripted for by the deadline: For the subscription of less than one share of abnormally zero shares, the shareholder shall go to the Company's stock agency to apply for a whole share subscription within five days from the date of suspension of transfer. The original shareholders and employees waived the subscription or obbled together the abnormal fractional share of less than one share, and authorized the chairman to negotiate a specific person to offtake at the issue price. 14.Rights and oblig...

View stock analysis, news, and events for Medigen Vaccine Biologics Corp.